Guidance
Update information
April 2017: We updated a recommendation in section 1.3 on corticosteroid treatment for people with severe alcoholic hepatitis.
|
Recommendations are marked as [2017], [2010, amended 2017] or [2010]. [2017] indicates that the evidence was reviewed and the recommendation updated in 2017. [2010, amended 2017] indicates that the evidence was reviewed in 2010, but changes were made to the recommendation wording in 2017 that changed the meaning. [2010] indicates that the evidence was reviewed in 2010. |
Recommendations that have been amended in 2017
|
Recommendation in 2010 guideline |
Recommendation in current guideline |
Reason for change |
|
In people with delirium tremens, offer oral lorazepam12 as first-line treatment. If symptoms persist or oral medication is declined, give parenteral lorazepam12, haloperidol13 or olanzapine14. (1.1.4.1) |
In people with delirium tremens, offer oral lorazepam7 as first-line treatment. If symptoms persist or oral medication is declined, offer parenteral lorazepam7 or haloperidol8. [2010, amended 2017] (1.1.4.1) |
Olanzapine has been removed because this formulation of olanzapine is no longer available. |
|
Refer patients with decompensated liver disease to be considered for assessment for liver transplantation if they: • still have decompensated liver disease after best management and 3 months' abstinence from alcohol and • are otherwise suitable candidates for liver transplantation15. (1.3.2.1) 15 See the nationally agreed guidelines for liver transplant assessment in the context of alcohol-related liver disease. |
Refer patients with decompensated liver disease to be considered for assessment for liver transplantation if they: • still have decompensated liver disease after best management and 3 months' abstinence from alcohol and • are otherwise suitable candidates for liver transplantation. [2010, amended 2017] (1.3.2.1) |
The footnote has been removed because these guidelines are no longer available online. |
ISBN: 978-1-4731-2477-6